- Michael F. Drummond, MCom, DPhil
- C. Daniel Mullins, PhD
- Associate Editors
- Editorial Advisory Boards
- Editorial Office
Editor-in-Chief
(May 2018 – June 2020)
University of York
Heslington, York, UK
Contact Editors
Michael F. Drummond is Professor of Health Economics and former Director of the Centre for Health Economics at the University of York. His particular field of interest is in the economic evaluation of healthcare treatments and programs. He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programs, services for people with AIDS, eye health care and pharmaceuticals. He is the author of two major textbooks and more than 550 scientific papers, has acted as a consultant to the World Health Organization and was Project Leader for the European Union Project on the Methodology of Economic Appraisal of Health Technology. He has been President of the International Society of Technology Assessment in Health Care, and ISPOR. He is currently a member of the Guidelines Review Panels of the National Institute for Health and Clinical Excellence (NICE) in the UK, and is a Principal Consultant for i3Innovus. In 2008, he received an Honorary Doctor of Science from City University, London.
Value in Health Vision Statement
Value in Health should duplicate ISPOR’s objectives to have the journal reflect the highest scientific quality as possible in the areas of methodological research and health care sciences, services, and policy, whilst maintaining the already broad appeal to the journal it has already attained, and continuing contributions from many world leaders associated with NICE, CMS, and major private health insurers around the globe.
Editor-in-Chief
(May 2018 – June 2022)
University of Maryland
Baltimore, MD, USA
Contact Editors
C. Daniel Mullins, PhD is a Professor and Chair of the Pharmaceutical Health Services Research Department at the University of Maryland School of Pharmacy. He is Founder and Executive Director of the University of Maryland PATient-centered Involvement in Evaluating effectiveNess of TreatmentS (PATIENTS) Program, an infrastructure to support patient-centered outcomes research and related training activities. He also serves as Director of the Community and Collaboration Core within the university’s Institute for Clinical and Translational Research. Dr. Mullins has received funding as a Principal Investigator from the NIH/NIA, NIH/NHLBI, AHRQ, the Patient-Centered Outcomes Research Institute (PCORI) and various patient advocacy and industry organizations. He has served as a Regular Member of AHRQ and NCI Study Sections and has chaired PCORI Study Sections.
Professor Mullins is author/co-author of more than 225 peer-reviewed articles. He has received an Outstanding Service Award from the Drug Information Association (DIA) and two Service Awards from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). In 2007, he received the Dr. Patricia Sokolove Outstanding Mentor Award from the University of Maryland Baltimore campus-wide Graduate Student Association. In 2013, he was the recipient of the Dr. Daniel D. Savage Memorial Science Award, the Association of Black Cardiologists’ most prestigious annual award. Also in 2013, he was awarded a University System of Maryland Wilson H. Elkins Professorship. He was named Researcher of the Year in 2014 and received the Martin Luther King Faculty Diversity Award in 2017 for the University of Maryland Baltimore campus and the ISPOR Marilyn Dix Smith Leadership Award.
Value in Health Vision Statement
As the journal of ISPOR, Value in Health should be viewed as interdependent of the Society and mirror its aim to enhance the methods and applications within the fields of health economics and outcomes research, with its content reflecting research that is read and used for medical decision making and reflect empirical applications of readable, reliable, and advanced methodologies with actionable results and conclusions.
Value in Health Associate Editors
Sarah Acaster, PSc, MSc
(August 2018 – November 2022)
Acaster Lloyd Consulting Ltd.
London, UK
Kalipso Chalkidou, MD, PhD
(November 2018 – November 2022)
Imperial College, University of London
London, UK
Joshua Cohen, PhD
(June 2017 – June 2021)
Independent Healthcare Analyst
Boston, MA, USA
Jalpa A. Doshi, PhD
(March 2015 – March 2019)
University of Pennsylvania
Philadelphia, PA, USA
David Epstein, MSc, PhD
(November 2015 – November 2019)
University of Granada
Granada, Spain
Manuel Espinoza, PhD, MD, MSc
(February 2018 – February 2022)
Pontificia Universidad Católica de Chile
Santiago, Chile
Alex Z. Fu, PhD
(April 2016 – April 2020)
Georgetown University
Washington, DC, USA
Ron Goeree, MA
(April 2016 – April 2020)
McMaster University
Hamilton, ON, Canada
Dan Greenberg, PhD
(February 2015 – February 2019)
Ben-Gurion University of the Negev
Beer-Shiva, Israel
Fei-Yuan Sharon Hsiao, PhD
(September 2018 – September 2022)
National Taiwan University
Taipei, 10050 TAIWAN
Stacie Hudgens, MA
(July 2016 – July 2020)
Clinical Outcomes Solutions LLC
Tucson, AZ, USA
Andrew Lloyd, DPhil, BSc
(August 2015 – April 2019)
Acaster Lloyd Consulting Ltd
London, UK
Lori McLeod, PhD
(January 2017 – January 2021)
RTI Health Solutions
Research Triangle Park, NC, USA
Claire Rothery McKenna, PhD
(November 2015 – November 2019)
University of York
York, UK
Axel Muehlbacher, PhD
(September 2018 – September 2022)
Neubrandenburg University
Neubrandenburg, Germany
Richard Norman
(March 2016 – March 2020)
Curtin University
Perth, Australia
Maarten Postma, PhD
(June 2017 – June 2021)
University of Groningen
Groningen, The Netherlands
Thomas Rapp, PhD
(July 2016 – July 2020)
Harvard University
Boston, MA, USA
Lizheng Shi, PhD, MsPharm, MA
(July 2018 – July 2022)
Tulane University
New Orleans, LA, USA
Elly Stolk, PhD
(September 2018 – September 2022)
EuroQol Research Foundation
Rotterdam, The Netherlands
Aleksandra Torbica, PhD
(November 2015 – November 2019)
Universita Bocconi,
Milan, Italy
David Vanness, PhD
(September 2018 – September 2022)
Pennsylvania State University
University Park, PA, USA
David Veenstra, PhD, PharmD
(June 2017 – June 2021)
University of Washington
Seattle, WA, USA
Allan Wailoo, PhD, BSc, MA
(April 2017 – April 2021)
University of Sheffield
Sheffield, UK
Danielle Whicher, PhD, MHS
(August 2018 – August 2022)
National Academy of Medicine
Washington, DC, USA
Value in Health Editorial Advisory Board
Alan Brennan, PhD
(March 2017 – March 2021)
University of Sheffield
Sheffield, UK
Kati Copley-Merriman, MS, MBA
(November 2014 – November 2018)
RTI-HS
Ann Arbor, MI, USA
John C. Hornberger, MD, MS
(March 2017 – March 2021)
Cedar Associates LLC
Menlo Park, CA, USA
Andrea Manca, PhD, MSc
(March 2016 – March 2020)
University of York
York, UK
Robert Ohsfeldt, PhD
(November 2017 – November 2021)
Texas A&M University (TAMU 1266)
College Station, TX, USA
Kathryn Phillips, PhD
(March 2017 – March 2021)
University of California San Francisco
San Francisco, CA, USA
Shelby Reed, PhD, RPh
(February 2017 – January 2021)
Duke Clinical Research Institute
Durham, NC, USA
Brian Rittenhouse, PhD
(March 2016 – March 2020)
Massachusetts College of Pharmacy and Health Services
Boston, MA, USA
Paul Scuffham, PhD, BA
(March 2016 – March 2020)
Griffith University
Queensland, Australia
Johan L. Severens, PhD
(April 2016 – April 2020)
Erasmus School of Health Policy & Management
Rotterdam, The Netherlands
Value in Health Management Advisory Board
Rosanna Tarricone, PhD, MSc (chair)
Bocconi University
Milan, Italy
Gordon G. Liu, PhD
Peking University National School of Development (NSD)
Bejing, China
Nancy Devlin
The University of Sheffield
London, UK
Jalpa A. Doshi, PhD
University of Pennsylvania
Philadelphia, PA, USA
Editorial Office
505 Lawrence Square Blvd South
Lawrenceville, NJ, USA 08648
Contact Editors
Stephen L. Priori
Director, Publications
Lyn Beamesderfer
Associate Director, Publications & Communications
Jennifer Brandt
Editorial Assistant